Quantity:
Ships from/sold by Buy.com
See All Buying Options
advertisement
Earn Super Points: Write a Review
Sorry, this selection is currently unavailable.
Evaluating Pharmaceuticals for Health Policy and Reimbursement Freemantle, Nick                        |Hill, Suzanne                            1 of 1
Today
$126.36  Free Budget Shipping
EARN 127 RAKUTEN SUPER POINTS™ Super Points
What are Rakuten Super Points™?
Get rewarded when you shop! Earn 1 point per dollar spent. That's like getting cash back on every purchase. Easy to see matured points in checkout. Use points just like cash.
Learn More
Format: Paperback
Condition:  Brand New
Temporarily Sold Out.:
More inventory may be available. Place your order today and be one of the first to receive this product when it arrives!
Alert me when this item is in stock.
1 New
from
$102.05
See all sellers
45 day return policy
Share

Product Details:

Format: Paperback
ISBN-10: 0727917846
ISBN-13: 9780727917843
Sku: 36339694
Publish Date: 4/10/2007
Dimensions:  (in Inches) 8.25H x 5.25L x 0.75T
Pages:  280
Age Range:  NA
See more in Health Care Delivery
 
"The challenge in all settings is to make the difficult decisions in a way that is defensible, justifiable, ethical, and equitable" So write Nick Freemantle and Suzanne Hill in their introduction to this important discussion on decision making in the reimbursement of pharmaceuticals. Based around a programme supported by the World Health Organization, chapters by leading academics involved in the research tackle such major issues as international pharmaceutical policy, tensions in licensing policies, priority setting, and relationships between the stakeholders. Chapters include - -Development of marketing authorisation procedures for pharmaceuticals -Interpreting clinical evidence -International pharmaceutical policy: health creation or wealth creation? -Development of fourth hurdle policies around the world -Economic modelling in drug reimbursement -Priority setting in health care: matching decision criteria with policy objectives -Tensions in licensing and reimbursement decisions: case of riluzole for amytrophic lateral sclerosis -Relationship between stakeholders: managing the war of words -Medicine and the media: good information or misleading hype? -How to promote quality use of cost-effective medicines -Using economic evaluation to inform health policy and reimbursement: making it happen and making it sustainable -Pricing of pharmaceuticals -Evaluating pharmaceuticals for health policy in low and middle income country settings. Besides the controversial issues there is a wealth of practical information including economic modelling and the experiences from the WHO programme, providing readers with workable examples. This is essential reading for clinical researchers inpharmaceuticals and policy makers everywhere.
Product Attributes
Product attributeeBooks:   Kobo
Product attributeBook Format:   Paperback
Product attributeNumber of Pages:   0280
Product attributePublisher:   Bmj Publishing Group
Advertisement Bottom
BloomReach Content